There is virtually no overlap between the two companies, and OEMs may seek commercial concessions but are unlikely to block the transaction.

Analysts say that aerospace manufacturing investments in low-cost countries peaked in the 2008-13 and declined significantly in the past three years.

The additive manufacturing-bionic design combination is analogous to the introduction of composites four decades ago.